Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/12/2009EP1274319B1 Compositions and methods for improving vascular health
08/12/2009EP1259608B1 Modified fluorescent proteins
08/12/2009EP1242105B3 Combination of ginseng and ginkgo to improve cognitive skills
08/12/2009EP1224170B1 6-position substituted indoline, production and use thereof as a medicament
08/12/2009EP1198589B9 Tenascin-c nucleic acid ligands
08/12/2009EP1149111B1 Method and composition for angiogenesis inhibition
08/12/2009EP1077941B1 Compounds with growth hormone releasing properties
08/12/2009EP0898580B9 Methods and means for inhibition of cdk4 activity
08/12/2009EP0788360B3 Boronic ester and acid compounds, synthesis and uses
08/12/2009EP0674505B2 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails
08/12/2009CN101506221A Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors
08/12/2009CN101506217A Crystal form of epothilone B and use in pharmaceutical compositions
08/12/2009CN101506216A Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase
08/12/2009CN101506215A Adenosine A2a receptor antagonists
08/12/2009CN101506214A Pyrazoloquinazolinones as PARP inhibitors
08/12/2009CN101506213A Amino- imidazolones and their use as a medicament for treating cognitive impairment. alzheimer disease, neurodegeneration and dementia.
08/12/2009CN101506212A Amino- imidazolones and their use as a medicament for treating cognitive impairment. alzheimer disease, neurodegeneration and dementia.
08/12/2009CN101506211A 激酶拮抗剂 Kinase antagonists
08/12/2009CN101506210A 2-phenoxy pyrimidinone analogues
08/12/2009CN101506209A Kw-3902 conjugates that do not cross the blood-brain barrier
08/12/2009CN101506208A Pyrrolo isoquinolines as kinase inhibitors
08/12/2009CN101506206A Inhibitors of Akt activity
08/12/2009CN101506205A Polymorph of (R) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-3-ylcarbamoyl-methyl) -1-azoni a-bicyclo- [2.2.2] octane bromide
08/12/2009CN101506204A Human protein tyrosine phosphatase inhibitors and methods of use
08/12/2009CN101506203A 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and o
08/12/2009CN101506202A mGluR5 modulators I
08/12/2009CN101506201A Novel heteroaryl substituted benzoxazoles
08/12/2009CN101506199A Azetidine compounds as orexin receptor antagonists
08/12/2009CN101506198A Substituted bicyclic and tricyclic thrombin receptor antagonists
08/12/2009CN101506196A Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
08/12/2009CN101506195A New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds
08/12/2009CN101506194A New pyridine analogues
08/12/2009CN101506193A New pyridine analogues
08/12/2009CN101506188A Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
08/12/2009CN101506186A Substituted n-acyl homoserine lactones
08/12/2009CN101506183A Human protein tyrosine phosphatase inhibitors and methods of use
08/12/2009CN101506182A Single enantiomer beta agonists method for production and use thereof as a medicament
08/12/2009CN101506181A Tricyclic compound and pharmaceutical use thereof
08/12/2009CN101506180A Human protein tyrosine phosphatase inhibitors and methods of use
08/12/2009CN101506179A Method of dynamic nuclear polarisation (DNP) and compounds and compositions for use in the method
08/12/2009CN101506177A 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as JAK kinases inhibitors
08/12/2009CN101506176A 2-anilino-4-aminoalkyleneaminopyrimidines
08/12/2009CN101506175A 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase C-alpha
08/12/2009CN101506172A Tartrate salt of (7s)-7-[(5-fluoro-2-methyl-benzyl)oxy]-2-[(2r)-2 -methylpiperazin-1-yl]-6,7-dihydro-5h-cyclopenta[b]pyridine
08/12/2009CN101506171A Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
08/12/2009CN101506170A 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as HIV integrase inhibitor
08/12/2009CN101506169A Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
08/12/2009CN101506168A Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
08/12/2009CN101506167A Viral polymerase inhibitors
08/12/2009CN101506165A Phenyl, pyridine and quinoline derivatives
08/12/2009CN101506164A Piperidine derivatives
08/12/2009CN101506162A Substituted isoindoles as bace inhibitors and their use
08/12/2009CN101506159A Compounds having CRTH2 antagonist activity
08/12/2009CN101506158A Novel 6-5 bicycic heterocyclic derivative and medical use thereof
08/12/2009CN101506157A Co-crystals of pyrrolidinones
08/12/2009CN101506156A Pyrrolidine derivatives having activity at the GlyT1 transporter
08/12/2009CN101506155A Biphenyl derivatives and their use in treating hepatitis C
08/12/2009CN101506154A Compounds for treating proliferative disorders
08/12/2009CN101506151A Improvement of the bioavailability of active substances having an amidine function in medicaments
08/12/2009CN101506145A Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
08/12/2009CN101506139A Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
08/12/2009CN101506138A Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
08/12/2009CN101505800A Preparation of pegylated conjugates of VLA-4 antagonists via a Mitsunobu's reaction
08/12/2009CN101505799A Pharmaceutical composition for administration by injection
08/12/2009CN101505798A Aerosol formulation for the inhalation of beta agonists
08/12/2009CN101505797A Pharmaceutical compositions for the treatment of fungal infections
08/12/2009CN101505796A Soft tissue repair and regeneration using stem cell products
08/12/2009CN101505788A Prophylactic and/or therapeutic agents for peripheral neuropathy
08/12/2009CN101505778A Hypoglycemic composition containing component originating in the bark of tree belonging to the genus acacia
08/12/2009CN101505777A Composition for preventing and/or treating tumor containing component originating in the bark of tree belonging to the genus acacia
08/12/2009CN101505776A Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia
08/12/2009CN101505775A Antioxidant composition containing component originating in the bark of tree belonging to the genus acacia
08/12/2009CN101505774A Composition for preventing and/or treating itching containing component originating in the bark of tree belonging to the genus acacia
08/12/2009CN101505773A Agent for treating eye diseases
08/12/2009CN101505768A Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
08/12/2009CN101505767A Agent for preventing infection
08/12/2009CN101505764A Drug composition for treating 2 type diabetes and its chronicity neopathy
08/12/2009CN101505763A Modulation of the immune system by inositol phospholipids
08/12/2009CN101505762A Orally active purine-based inhibitors of heat shock protein 90
08/12/2009CN101505761A Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
08/12/2009CN101505760A Combinations comprising staurosprorines
08/12/2009CN101505759A Method of treating thermoregulatory disfunction with paroxetine
08/12/2009CN101505758A Pharmaceutical containing thiazole derivative as active ingredient
08/12/2009CN101505757A Drug combinations for treating airway diseases
08/12/2009CN101505756A Transdermal application of triazines for controlling coccidia infections
08/12/2009CN101505755A Agent for overcoming resistance to anti-cancer agent
08/12/2009CN101505754A Compositions, suitable for oral administration, comprising a triazolo [4, 5-d]pyrimidin derivate
08/12/2009CN101505753A Compounds and compositions for treatment of cancer
08/12/2009CN101505752A Prolyl hydroxylase inhibitors
08/12/2009CN101505751A 8-hydroxyquinoline compounds and methods thereof
08/12/2009CN101505750A Sugar-free storage-stable antihistaminic syrups
08/12/2009CN101505749A Use of PKC inhibitors in particular indolylmaleimide derivatives in ocular diseases
08/12/2009CN101505748A Quercetin-containing compositions
08/12/2009CN101505747A Pyrazinones as cellular proliferation inhibitors
08/12/2009CN101505746A Treatment of inflammatory conditions
08/12/2009CN101505745A Methods and compositions for improving cognitive function
08/12/2009CN101505744A Antagonists of endothelial differentiation gene subfamily 3 (EDG-3, S1P3) receptors for prevention and treatment of ocular disorders
08/12/2009CN101505743A Hexahydro-isoalpha acid based protein kinase modulation cancer treatment
08/12/2009CN101505742A Beta acid based protein kinase modulation cancer treatment
08/12/2009CN101505741A A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
1 ... 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 ... 7860